Dendritic Cell Vaccine

Dendritic Cell (DC) therapy (vaccine) represents a new and promising immunotherapeutic approach for treatment of tick-borne diseases. The vaccine is created from cells pulled from the patient’s own blood. When the vaccine is given to the patient, the dendritic cells will transport into the lymphatic system, activating white cells to kill the selected bacteria. DC therapy is a safe option as it creates an immune response in a similar way of a vaccine.

The mechanism starts by maturing one’s dendritic cells (antigen presenting cells) and incubating them with parastical and bacterial peptides obtained by UV irradiation. These mature cells help the immune system capture and eliminate pathogens effectively, passing along this information to other developing cells and creating a chain of endless immune response. Usually a portion of a Lyme patient’s immune cells remains immature due to a proteing expressed by b. Burgdorferi that inhibits cellular phases.

Activating Macrophage Therapy

There are essential human proteins our bodies make that can aid in removing a number of diseases. Activating Macrophage Therapy is a replacement therapy for those that can’t make their own proteins, and has been known to cure chronic illness by activating macrophage white blood cell production.

IVIG

The body’s immune system normally makes enough antibodies to fight off infections. Lyme disease and tick-borne diseases can cause your immune system to not make enough antibodies to fight of the bacteria. Intravenous Immunoglobulin Therapy (IVIG) pulls antibodies from healthy donors’ plasma. The healthy antibodies are given through an IV to replace the weak or nonexistent antibodies in an effort to strengthen the immune system.

Autonosode

A nosode is prepared from a viral or bacterial culture. It carries the molecular imprint of the pathogenic agent. When prepared properly, the remedy is free of toxins. An auto-nosode is made from autologous material that is derived from the patient. The auto-nosode is therefore an isopathic therapy using blood from the patient as a medicine to treat a condition that the patient is not creating a response to. The therapeutic mechanism is one of desensitisation. The body reacts to and uses the electromagnetic energy provided by the nosode as a stimulus to strengthen the immune response and thereby counteract any effects caused by the pathogen or toxin. Lyme auto-nosode therapy has allowed several patients to obtain noticeable immunological improvements, specially those cases where CD4 expression has been majorly affected by the bacterial surface proteins.

Low Dose Immunotherapy (LDI) and Low Dose Allergen Immunotherapy (LDA)

Allergies and autoimmune diseases have a common denominator that is based on an “over excitability” of the immune system. It essentially creates an intolerance to either substances that come from the “outside” environment or an intolerance to the tissues of one’s own “inside” body.

By giving specifically made, diluted and ultrahigh diluted antigens (hence the word “low-dose antigens” (LDA) or “low-dose immunotherapy” (LDI), we teach the immune system to develop a new tolerance and behave in a more normal physiological fashion. As a result, food/chemical sensitivities will ideally disappear and allergies and autoimmune diseases (such as arthritis, thyroiditis, etc.) are controlled.